Pennsylvania House unanimously approves bill to extend moratorium protecting seniors' eligibility for PACE and PACENET prescription drug programs through 2027.

Analysis of the Center for Medicare & Medicaid Innovation's costly projects and their impact on Medicare and Medicaid financial efficiency.

CMS finalizes key aspects of the 2026 Medicare Advantage and Part D programs rule, including expanded insulin coverage, payment plans, and new pharmacy requirements for network participation.

Explore how dance enhances physical fitness, mental health, and social connections in older adults, backed by recent research and health guidelines.

Elevance Health lowers full-year profit forecast despite Q1 revenue growth driven by higher premiums and membership gains in Medicare Advantage and ACA.

Reveleer acquires Novillus to enhance its AI-driven value-based care platform, improving payer-provider collaboration, care gap closure, and clinical intelligence for health plans.

Explore key U.S. healthcare reforms to improve support for Alzheimer's caregivers, addressing systemic challenges and policy opportunities for dementia care.

Elevance Health reports 15% revenue growth in Q1 2025 driven by Medicare Advantage expansion, premium increases, and CarelonRx portfolio growth, highlighting ongoing healthcare market evolution.

Medicare's ongoing pay cuts strain primary care physicians, intensifying doctor shortages and risking access to care for the growing senior population. Increased audits and complex billing compound challenges, pushing some doctors out of Medicare.

President Trump's executive order prompts potential changes in Medicare drug price negotiation, affecting pharmaceutical pricing, Medicare spending, and FDA drug import regulations. Epic Systems also shifts to a more public presence in healthcare IT.